Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Researchers assessed the impact of BCG vaccination on the protection provided by SARS-CoV-2 vaccination.

28 Mar 2023

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.

28 Mar 2023

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

In a recent case report published in the U.S. Centers for Disease Control and Prevention’s (CDC) journal Emerging Infectious Diseases, researchers reported a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Nocardia pseudobrasiliensis concomitant infection.

27 Mar 2023

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

How can Europe tackle its unfinished tuberculosis business?

A recent Eurosurveillance journal editorial discussed the progress in the EU/EEA, between 2018 and 2021, towards achieving the 2030 targets for TB elimination.

27 Mar 2023

On current trajectory, Euro region will not achieve sustainable development goals for tuberculosis reduction

A recent study assessed the progress toward the Sustainable Development Goals (SDG) targets for tuberculosis (TB) elimination.

27 Mar 2023

Epigenome reprogramming after SARS-CoV-2 infection

Researchers performed a 3D evaluation of SARS-CoV-2 infected human cells.

27 Mar 2023

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

Researchers investigated the effects of the booster coronavirus disease 2019 (COVID-19) vaccine during pregnancy on COVID-19-related hospitalization rates among infants.

27 Mar 2023

How did the prevalence of autism spectrum disorders change before and during COVID-19?

Researchers reported on autism spectrum disorders prevalence among four-year-old children.

27 Mar 2023

Estimating the risk of contact transmission of COVID-19 for indoor environments

While COVID-19 can be transmitted via contact with contaminated objects, most studies have focused on airborne droplet transmission.

27 Mar 2023

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

A recent study reported growing cases of Candida auris in North Italy.

27 Mar 2023

Study reveals new insights into how different countries' research establishments respond to disease

In a new study, researchers examined how a country's number of published 3D protein structures for coronaviruses, including the one responsible for COVID-19, correlated with its economic output and population.

27 Mar 2023

Government’s new funding to transform hundreds of youth facilities in deprived areas

Young people are to benefit from the rebuilding and renovation of youth centers in some of the country's most disadvantaged areas, as beneficiaries of the first major tranche from the Government's Youth Investment Fund have been announced today.

27 Mar 2023

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Researchers in the United States assessed the risk associated with SARS-CoV-2 reinfection.

27 Mar 2023

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Researchers performed an observational cohort study using the US Department of Veterans Affairs healthcare databases.

27 Mar 2023

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

In a recent study published in JAMA Network Open, researchers in Tennessee investigated whether the coronavirus disease 2019 (COVID-19) pandemic altered daily step counts among individuals participating in All of Us (AOU) research programs.

27 Mar 2023

The vital role of patients and the general public in guiding long-COVID research

In a recent study published in the journal Nature Medicine, researchers in the United Kingdom (UK) emphasized the significance of public and patient involvement (PPI) in scientific studies on long coronavirus disease (COVID).

27 Mar 2023

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

In a recent prospective study published in the Annals of Internal Medicine Journal, researchers in the United States (US) and Spain performed a randomized controlled trial (RCT) across 127 US hospitals between 2021 and 2022.

27 Mar 2023

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

A new study published in the Nutrients Journal highlights the impact of curcumin supplementation on the immune response following the immunization of Coronavirus disease 2019 (COVID-19) survivors with a primary series of monovalent COVID-19 vaccines.

26 Mar 2023

Incidence of tuberculosis reaches 2.5 cases per 100,00 in the U.S.

The United States (US) Centers for Disease Control and Prevention (CDC) has recently released preliminary data on tuberculosis incidence in the US in 2022. The report is published in the Morbidity and Mortality Weekly Report.

26 Mar 2023

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

New study suggests broad neutralizing antibody could provide three years of COVID protection

How can Europe tackle its unfinished tuberculosis business?

On current trajectory, Euro region will not achieve sustainable development goals for tuberculosis reduction

Epigenome reprogramming after SARS-CoV-2 infection

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

How did the prevalence of autism spectrum disorders change before and during COVID-19?

Estimating the risk of contact transmission of COVID-19 for indoor environments

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

Study reveals new insights into how different countries' research establishments respond to disease

Government’s new funding to transform hundreds of youth facilities in deprived areas

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

The vital role of patients and the general public in guiding long-COVID research

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

Incidence of tuberculosis reaches 2.5 cases per 100,00 in the U.S.

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in